According to Actinium Pharmaceuticals's latest financial reports the company's total liabilities are $44.49 M. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2022-12-31 | $47.71 M | 597.22% |
2021-12-31 | $6.84 M | 34.76% |
2020-12-31 | $5.07 M | -15.73% |
2019-12-31 | $6.02 M | -0.83% |
2018-12-31 | $6.07 M | 30.23% |
2017-12-31 | $4.66 M | 3.22% |
2016-12-31 | $4.52 M | -2.02% |
2015-12-31 | $4.61 M | -51.39% |
2014-12-31 | $9.49 M | 29.57% |
2013-12-31 | $7.32 M | 57.76% |
2012-12-31 | $4.64 M | -10.85% |
2011-12-31 | $5.2 M | 5396.04% |
2010-12-31 | $0.09 M | -3.7% |
2009-12-31 | $0.09 M | 29.19% |
2008-12-31 | $0.07 M | 69.17% |
2007-12-31 | $0.04 M | 138.64% |
2006-12-31 | $0.01 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Genocea Biosciences
GNCA | $26.4 M | -40.66% | ๐บ๐ธ USA |
Amicus Therapeutics
FOLD | $0.61 B | 1,288.26% | ๐บ๐ธ USA |
BioMarin Pharmaceutical BMRN | $1.79 B | 3,942.84% | ๐บ๐ธ USA |